RedHill Biopharma Plans to File for UK Approval of H.Pylori Treatment

MT NewswiresMar 18 20:01

RedHill Biopharma Plans To Submit FDA Approved Talicia Used To Treat H. Pylori Infection For UK Marketing Approval

BenzingaMar 18 19:13

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 15:00

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 20:50

RedHill Biopharma Initiates Phase 2 Study Of RHB-204 In Mycobacterium Avium Subspecies Paratuberculosis-Positive Moderate To Severe CD

BenzingaMar 12 19:03

RedHill Biopharma Licenses RHB-102 to Hyloris for Global Markets

TipRanksFeb 25 20:27

Market-Moving News for February 25th

BenzingaFeb 25 20:15

RedHill Shares Are Trading Higher After the Company Announced an Exclusive Licensing Agreement With Hyloris Pharmaceuticals for RHB-102, Including an Upfront Payment and up to $60 Million in Potential Milestones.

BenzingaFeb 25 20:05

RedHill Enters Exclusive Development And Commercialization Licensing Agreement With Hyloris Pharmaceuticals For RHB-102; Hyloris Will Pay Co. Upfront Payment And Up To $60M In Potential Milestones

BenzingaFeb 25 20:05

RedHill Licenses RHB-102 for Commercialization Worldwide Excluding North America to Hyloris for up to $60 Million in Potential Milestone Payments Plus Royalties

Redhill BiopharmaFeb 25 13:00

RedHill Biopharma Launches Trial of Combination Therapy for Prostate Cancer

Yahoo FinanceFeb 5 19:45

RedHill Biopharma Begins Phase 2 Study of Opaganib, Darolutamide for Advanced Prostate Cancer; Shares Rise

MT NewswiresFeb 4 23:37

RedHill Initiates Phase 2 Study Of Opaganib And Darolutamide For Advanced Prostate Cancer

BenzingaFeb 4 20:14

RedHill Announces Initiation of Phase 2 Study of Opaganib and Darolutamide in Advanced Prostate Cancer

Redhill BiopharmaFeb 4 13:00

RedHill Biopharma Engages in Strategic Market Offering to Boost Financial Flexibility

TipRanksFeb 4 05:49

Redhill Biopharma May Offer, Sell ADS Of Up To $3.5M From Time To Time; Entered Into At Market Offering Agreement Relating To Offer From Time To Time Of ADSs Offered By Prospectus Supplement

BenzingaFeb 4 05:29

Redhill Biopharma | 6-K: Report of foreign private issuer (related to financial reporting)

SECFeb 3 22:09 · Announcements

RedHill Biopharma Expands Medicare Coverage and Simplifies Talicia Dosing

TipRanksJan 21 20:28

RedHill Biopharma Advances Opaganib for GI-ARS Treatment

TipRanksDec 10, 2024 20:28

RedHill Biopharma Announced Results From New In Vivo Studies Of Opaganib For Gastrointestinal Acute Radiation Syndrome, Undertaken As Part Of The U.S. Government's Radiation And Nuclear Countermeasures Program Contract That Further Confirms Opaganib's...

BenzingaDec 10, 2024 20:14